{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T11:54:15Z","timestamp":1761393255334},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1016\/j.atherosclerosis.2004.10.025","type":"journal-article","created":{"date-parts":[[2004,12,16]],"date-time":"2004-12-16T05:30:23Z","timestamp":1103175023000},"page":"27-33","source":"Crossref","is-referenced-by-count":25,"title":["Intravascular adenovirus-mediated lipoprotein-associated phospholipase A2 gene transfer reduces neointima formation in balloon-denuded rabbit aorta"],"prefix":"10.1016","volume":"179","author":[{"given":"P\u00e4ivi","family":"Turunen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"Puhakka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juha","family":"Rutanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikko O.","family":"Hiltunen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommi","family":"Heikura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcin","family":"Gruchala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seppo","family":"Yl\u00e4-Herttuala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2004.10.025_bib1","doi-asserted-by":"crossref","unstructured":"Bittl JA. Advances in coronary angioplasty [published erratum appears in N Engl J Med 1997 Feb 27;336(9):670]. N Engl J Med 1996;335:1290\u2013302.","DOI":"10.1056\/NEJM199610243351707"},{"key":"10.1016\/j.atherosclerosis.2004.10.025_bib2","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/0735-1097(90)92845-S","article-title":"Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation","volume":"15","author":"Ip","year":"1990","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2004.10.025_bib3","first-page":"III47","article-title":"A cascade model for restenosis. A special case of atherosclerosis progression","volume":"86","author":"Libby","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.025_bib4","first-page":"III53","article-title":"Induction of PDGF-responsive genes in vascular smooth muscle Implications for the early response to vessel injury","volume":"86","author":"Marmur","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.025_bib5","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/S0735-1097(96)00417-2","article-title":"Role of platelets in restenosis after percutaneous coronary revascularization","volume":"28","author":"Le Breton","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2004.10.025_bib6","first-page":"898","article-title":"Role of platelet activating factor in propagation of cardiac damage during myocardial ischemia","volume":"244","author":"Stahl","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.atherosclerosis.2004.10.025_bib7","doi-asserted-by":"crossref","first-page":"11095","DOI":"10.1016\/S0021-9258(18)99132-5","article-title":"Human plasma platelet-activating factor acetylhydrolase. Oxidatively fragmented phospholipids as substrates","volume":"266","author":"Stremler","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2004.10.025_bib8","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/0735-1097(95)00563-3","article-title":"Neutrophil and platelet activation at balloon-injured coronary artery plaque in patients undergoing angioplasty","volume":"27","author":"Neumann","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2004.10.025_bib9","doi-asserted-by":"crossref","first-page":"660","DOI":"10.4049\/jimmunol.147.2.660","article-title":"Differential synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine and platelet-activating factor by human inflammatory cells","volume":"147","author":"Triggiani","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.atherosclerosis.2004.10.025_bib10","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/jcp.1041390206","article-title":"Interaction of platelet-activating factor with endothelial and vascular smooth muscle cells in coculture","volume":"139","author":"Stoll","year":"1989","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.atherosclerosis.2004.10.025_bib11","doi-asserted-by":"crossref","first-page":"S294","DOI":"10.1097\/00003246-200205001-00020","article-title":"The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis","volume":"30","author":"Zimmerman","year":"2002","journal-title":"Crit Care Med"},{"key":"10.1016\/j.atherosclerosis.2004.10.025_bib12","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/S0891-5849(00)00240-9","article-title":"Vascular oxidant stress early after balloon injury: evidence for increased NAD(P)H oxidoreductase activity","volume":"28","author":"Souza","year":"2000","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.atherosclerosis.2004.10.025_bib13","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJM199708073370601","article-title":"Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. Multivitamins and Probucol Study Group","volume":"337","author":"Tardif","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2004.10.025_bib14","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1161\/01.CIR.0000031331.05368.9D","article-title":"Adenovirus-mediated extracellular superoxide dismutase gene therapy reduces neointima formation in balloon-denuded rabbit aorta","volume":"106","author":"Laukkanen","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.025_bib15","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1161\/01.ATV.16.4.591","article-title":"Purification, properties, sequencing, and cloning of a lipoprotein-associated, serine-dependent phospholipase involved in the oxidative modification of low-density lipoproteins","volume":"16","author":"Tew","year":"1996","journal-title":"Arteriosclerosis Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2004.10.025_bib16","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1089\/hum.1998.9.10-1481","article-title":"Adenovirus-mediated gene transfer to lower limb artery of patients with chronic critical leg ischemia","volume":"9","author":"Laitinen","year":"1998","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.atherosclerosis.2004.10.025_bib17","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1194\/jlr.M400176-JLR200","article-title":"Adenovirus-mediated gene transfer of Lp-PLA2 reduces LDL degradation and foam cell formation in vitro","volume":"45","author":"Turunen","year":"2004","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2004.10.025_bib18","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1161\/01.CIR.102.18.2262","article-title":"Intravascular adenovirus-mediated VEGF-C gene transfer reduces neointima formation in balloon-denuded rabbit aorta","volume":"102","author":"Hiltunen","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.025_bib19","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1089\/10430340050016003","article-title":"Catheter-mediated vascular endothelial growth factor gene transfer to human coronary arteries after angioplasty","volume":"11","author":"Laitinen","year":"2000","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.atherosclerosis.2004.10.025_bib20","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1161\/01.CIR.0000117234.08626.7C","article-title":"Oral imatinib mesylate (STI571\/gleevec) improves the efficacy of local intravascular vascular endothelial growth factor-C gene transfer in reducing neointimal growth in hypercholesterolemic rabbits","volume":"109","author":"Leppanen","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.025_bib21","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0735-1097(96)00164-7","article-title":"Leukocyte activation with platelet adhesion after coronary angioplasty: a mechanism for recurrent disease?","volume":"28","author":"Mickelson","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2004.10.025_bib22","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/0735-1097(95)00563-3","article-title":"Neutrophil and platelet activation at balloon-injured coronary artery plaque in patients undergoing angioplasty","volume":"27","author":"Neumann","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2004.10.025_bib23","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/jcp.1041390206","article-title":"Interaction of platelet-activating factor with endothelial and vascular smooth muscle cells in coculture","volume":"139","author":"Stoll","year":"1989","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.atherosclerosis.2004.10.025_bib24","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1172\/JCI118288","article-title":"Oxidatively modified LDL contains phospholipids with platelet- activating factor-like activity and stimulates the growth of smooth muscle cells","volume":"96","author":"Heery","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2004.10.025_bib25","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1172\/JCI116491","article-title":"Hypercholesterolemia increases endothelial superoxide anion production","volume":"91","author":"Ohara","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2004.10.025_bib26","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1161\/01.CIR.103.20.2495","article-title":"Adenovirus-mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice","volume":"103","author":"Quarck","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.025_bib27","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1096\/fj.99-1029com","article-title":"HDL-associated PAF-AH reduces endothelial adhesiveness in apoE-\/- mice","volume":"14","author":"Theilmeier","year":"2000","journal-title":"FASEB J"},{"key":"10.1016\/j.atherosclerosis.2004.10.025_bib28","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/S0006-2952(03)00559-8","article-title":"Effect of hypolipidemic drugs on lipoprotein-associated platelet activating factor acetylhydrolase. Implication for atherosclerosis","volume":"66","author":"Eisaf","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2004.10.025_bib29","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00041433-200406000-00015","article-title":"Platelet-activating factor acetylhydrolase: is it good or bad for you?","volume":"15","author":"Chen","year":"2004","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2004.10.025_bib30","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0021-9150(99)00406-2","article-title":"Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery disease","volume":"150","author":"Caslake","year":"2000","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2004.10.025_bib31","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1161\/01.RES.87.3.184","article-title":"Vascular cell apoptosis in remodeling, restenosis, and plaque rupture","volume":"87","author":"Walsh","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2004.10.025_bib32","doi-asserted-by":"crossref","first-page":"32315","DOI":"10.1074\/jbc.272.51.32315","article-title":"Protection against oxidative stress-induced cell death by intracellular platelet-activating factor-acetylhydrolase II","volume":"272","author":"Matsuzawa","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2004.10.025_bib33","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1046\/j.1365-2249.2001.01483.x","article-title":"The impact of platelet-activating factor (PAF)-like mediators on the functional activity of neutrophils: anti-inflammatory effects of human PAF-acetylhydrolase","volume":"123","author":"Kuijpers","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.atherosclerosis.2004.10.025_bib34","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1161\/01.CIR.0000065220.70220.F7","article-title":"Low-density lipoprotein in hypercholesterolemic human plasma induces vascular endothelial cell apoptosis by inhibiting fibroblast growth factor 2 transcription","volume":"107","author":"Chen","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.025_bib35","doi-asserted-by":"crossref","unstructured":"Beohar N, Flaherty JD, Davidson CJ, et al. Antirestenotic effects of a locally delivered caspase inhibitor in a balloon injury model. Circulation 2003;6;109(1):108\u201313.","DOI":"10.1161\/01.CIR.0000105724.30980.CD"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915004005490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915004005490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T22:58:40Z","timestamp":1682895520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915004005490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S0021915004005490"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2004.10.025","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}